Your browser doesn't support javascript.
loading
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.
Pastore, Alessandro; Jurinovic, Vindi; Kridel, Robert; Hoster, Eva; Staiger, Annette M; Szczepanowski, Monika; Pott, Christiane; Kopp, Nadja; Murakami, Mark; Horn, Heike; Leich, Ellen; Moccia, Alden A; Mottok, Anja; Sunkavalli, Ashwini; Van Hummelen, Paul; Ducar, Matthew; Ennishi, Daisuke; Shulha, Hennady P; Hother, Christoffer; Connors, Joseph M; Sehn, Laurie H; Dreyling, Martin; Neuberg, Donna; Möller, Peter; Feller, Alfred C; Hansmann, Martin L; Stein, Harald; Rosenwald, Andreas; Ott, German; Klapper, Wolfram; Unterhalt, Michael; Hiddemann, Wolfgang; Gascoyne, Randy D; Weinstock, David M; Weigert, Oliver.
Afiliação
  • Pastore A; Department of Internal Medicine III, University Hospital of the Ludwig-Maximilians-University Munich, Munich, Germany.
  • Jurinovic V; Department of Internal Medicine III, University Hospital of the Ludwig-Maximilians-University Munich, Munich, Germany; Institute for Medical Informatics, Biometry and Epidemiology, Ludwig-Maximilians-University Munich, Munich, Germany.
  • Kridel R; Department of Lymphoid Cancer Research and the Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Hoster E; Department of Internal Medicine III, University Hospital of the Ludwig-Maximilians-University Munich, Munich, Germany; Institute for Medical Informatics, Biometry and Epidemiology, Ludwig-Maximilians-University Munich, Munich, Germany.
  • Staiger AM; Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart, Germany; Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tübingen, Tübingen, Germany.
  • Szczepanowski M; Haematopathology Section, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Pott C; Second Medical Department, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Kopp N; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Murakami M; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Horn H; Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart, Germany; Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tübingen, Tübingen, Germany.
  • Leich E; Institute of Pathology, University of Würzburg, and Comprehensive Cancer Center Mainfranken, Würzburg, Germany.
  • Moccia AA; Department of Lymphoid Cancer Research and the Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Mottok A; Department of Lymphoid Cancer Research and the Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Sunkavalli A; Center for Cancer Genome Discovery, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Van Hummelen P; Center for Cancer Genome Discovery, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Ducar M; Center for Cancer Genome Discovery, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Ennishi D; Department of Lymphoid Cancer Research and the Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Shulha HP; Department of Lymphoid Cancer Research and the Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Hother C; Department of Lymphoid Cancer Research and the Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Connors JM; Department of Lymphoid Cancer Research and the Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Sehn LH; Department of Lymphoid Cancer Research and the Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Dreyling M; Department of Internal Medicine III, University Hospital of the Ludwig-Maximilians-University Munich, Munich, Germany.
  • Neuberg D; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Möller P; Institute of Pathology, University of Ulm, Ulm, Germany.
  • Feller AC; Department of Pathology, University Hospital of Schleswig-Holstein, Lübeck, Germany.
  • Hansmann ML; Senckenberg Institute of Pathology, Goethe University, Frankfurt am Main, Germany.
  • Stein H; Berlin Reference Center for Lymphoma and Haematopathology, Berlin, Germany.
  • Rosenwald A; Institute of Pathology, University of Würzburg, and Comprehensive Cancer Center Mainfranken, Würzburg, Germany.
  • Ott G; Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart, Germany.
  • Klapper W; Haematopathology Section, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Unterhalt M; Department of Internal Medicine III, University Hospital of the Ludwig-Maximilians-University Munich, Munich, Germany.
  • Hiddemann W; Department of Internal Medicine III, University Hospital of the Ludwig-Maximilians-University Munich, Munich, Germany; Clinical Cooperative Group Leukemia, Helmholtz-Center Munich, Munich, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; German Cancer Research Center (DKFZ), Heidelberg
  • Gascoyne RD; Department of Lymphoid Cancer Research and the Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Weinstock DM; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Weigert O; Department of Internal Medicine III, University Hospital of the Ludwig-Maximilians-University Munich, Munich, Germany; Clinical Cooperative Group Leukemia, Helmholtz-Center Munich, Munich, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; German Cancer Research Center (DKFZ), Heidelberg
Lancet Oncol ; 16(9): 1111-1122, 2015 Sep.
Article em En | MEDLINE | ID: mdl-26256760
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Folicular / Anticorpos Monoclonais Murinos / Imunoterapia / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Folicular / Anticorpos Monoclonais Murinos / Imunoterapia / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido